LIBRAX
LIBRAX
Approved
DIN Number
00115630
Drug Class
Human
Market Date
Dec 31, 1961
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00115630
AIG Number0200614001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
A03CA02 CLIDINIUM AND PSYCHOLEPTICS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
CHLORDIAZEPOXIDE HYDROCHLORIDEActive
Strength: 5 MG
Monograph: CHLORDIAZEPOXIDE HYDROCHLORIDE
CLIDINIUM BROMIDEActive
Strength: 2.5 MG
Monograph: CLIDINIUM BROMIDE